Question-based Drug Development for psilocybin – Authors' reply

OPEN Foundation
August 24, 2016

OPEN Foundation

Share This Post

get the latest

The OPEN Minded Newsletter keeps you informed about the latest psychedelic research & news, articles, exclusive events, job opportunities, programmes, and free resources!

By clicking SUBSCRIBE, I confirm to receive emails from the OPEN Foundation and agree with its privacy policy.

Recent articles & news

Psychedelics vs Antidepressants: What a New Meta-Analysis Really Shows

Truffles, therapy, disciplinary law – An OPEN perspective on the grey area in which (licensed) therapists operate in the Netherlands with regard to psychedelics

Truffels, therapie, tuchtrecht: Een OPEN perspectief op het grijze gebied waarin (BIG-geregistreerde) therapeuten opereren in Nederland met betrekking tot psychedelica

Science Revisits Kykeon: The Enduring Enigma of the Eleusinian Mysteries

Attachment Meets Psychedelics: What the Research Suggests So Far

Bridging Research and Policy: PsyPal Publishes EU-Funded Guidance on Psychedelic Therapy

Psilocybin vs Nicotine Patches: What a New Study Reveals About Quitting Smoking

The Therapeutic Potential of Psychedelics in the Treatment of Substance Use Disorders

Ketamine-Assisted Psychotherapy for Mental Disorders: What Does the Evidence Actually Show?

Question-based Drug Development for psilocybin – Authors' reply

OPEN Foundation

Share This Post

get the latest

Recent articles & news

OPEN

ABOUT

EVENTS

RESOURCES

PROGRAMMES

ACTIONS

Question-based Drug Development for psilocybin – Authors' reply

OPEN Foundation

Share This Post

get the latest

Recent articles & news

OPEN

ABOUT

EVENTS

RESOURCES

PROGRAMMES

ACTIONS

Join an upcoming event

Be at the forefront of psychedelic research and therapy